Randomized Comparison of Bare Metal or Drug-Eluting Stent versus Drug Coated Balloon in Non-ST-Elevation Myocardial Infarction - PEPCAD NSTEMI.
Two hundred and ten patients with Non-ST-Elevation Myocardial Infarction were randomized. Mean age was 67±12 years, 67% were male, 62% had multivessel disease, and 31% were diabetics. In the stent group, 56% of patients were treated with BMS, 44% with current generation DES. In the DCB group, 85% of patients were treated with DCB only whereas 15% underwent additional stent implantation. During a follow-up of 9.2 ± 0.7 months, DCB treatment was noninferior to stent treatment with a target lesion failure (TLF) of 3.8% vs 6.6% (intention-to-treat, p=0.53). Total MACE rate was 6.7% for DCB vs 14.2% for stent treatment (p=0.11), and 5.9% vs. 14.4% in the per protocol analysis (p=0.056), respectively.